Basic Information
| LncRNA/CircRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152 |
| Region | GRCh38_2:87454781-87636740 |
| Ensemble | ENSG00000222041 |
| Refseq | NR_024204 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | Microarray, qPCR, RNAi, Western blot etc. |
| Sample | gastric cancer tissues, cell lines (HCG-27, SGC-7901) |
| Expression Pattern | up-regulated |
| Function Description | Linc00152 was validated to be increased in 59 paired gastric cancer specimens (Fig. 3C), and the high levels of Linc00152 expression correlated with larger tumor size. |
| Pubmed ID | 26237576 |
| Year | 2015 |
| Title | Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. |
External Links
| Links for LINC00152 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |